Anna Teresa Bagnato

Medicine & Life Sciences

1. Endothelin-1 100%
2. Endothelin A Receptors 78%
3. Ovarian Neoplasms 35%
4. Endothelins 28%
5. Carcinoma 28%
6. Endothelin Receptors 24%
7. Neoplasms 23%
8. Arrestin 22%
9. macitentan 16%
10. ZD4054 16%
11. Ovarian Epithelial Carcinoma 16%
12. Growth 15%
13. Atrasentan 15%
14. Endothelin A Receptor Antagonists 13%
15. Vascular Endothelial Growth Factor A 12%
16. Endothelin B Receptors 12%
17. Epithelial-Mesenchymal Transition 10%
18. Hypoxia-Inducible Factor 1 10%
19. lonidamine 9%
20. Podosomes 9%
21. Catenins 9%
22. Endothelin Receptor Antagonists 9%
23. integrin-linked kinase 9%
24. Melanoma 8%
25. Endothelial Cells 8%
26. Paclitaxel 8%
27. Neoplasm Metastasis 8%
28. Therapeutics 6%
29. Cell Movement 6%
30. Doxorubicin 6%
31. Ehrlich Tumor Carcinoma 6%
32. G-Protein-Coupled Receptors 6%
33. ErbB Receptors 5%
34. Heterografts 5%
35. Cell Proliferation 5%
36. Hypoxia 5%
37. Growth Hormone-Releasing Hormone 5%
38. Phosphorylation 5%
39. Kaposi's Sarcoma 5%
40. Keratinocytes 5%
41. Transcriptional Activation 5%